Reactive oxygen species: an Achilles’ heel of melanoma?

2-year overall survival (OS) results of a phase II trial of elesclomol (formerly STA-4783) and paclitaxel in stage IV metastatic melanoma (MM)

(2017) D. H. Lawson et al.   JOURNAL OF CLINICAL ONCOLOGY

The MAPK pathway in melanoma

(2009) Leslie A Fecher et al.   CURRENT OPINION IN ONCOLOGY

Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape

(2009) Aleksandar Sekulic et al.   MAYO CLINIC PROCEEDINGS

Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases

(2009) Timothy E. Bael et al.   MELANOMA RESEARCH

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)

(2008) F Doñate et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma

(2008) Ahmad A. Tarhini et al.   CANCER

Mitochondrial complex III regulates hypoxic activation of HIF

(2008) T Klimova et al.   CELL DEATH AND DIFFERENTIATION

Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic

(2008) Andy T.Y. Lau et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group

(2008) David F. McDermott et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

(2008) Edward L. Korn et al.   JOURNAL OF CLINICAL ONCOLOGY

Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?

(2008) B. D. Lawenda et al.   JNCI-Journal of the National Cancer Institute

Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis

(2008) Elizabeth A. Grimm et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Melanosomal Damage in Normal Human Melanocytes Induced by UVB and Metal Uptake—A Basis for the Pro-oxidant State of Melanoma

(2008) Shirley Gidanian et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Increased Melanogenesis is a Risk Factor for Oxidative DNA Damage— Study on Cultured Melanocytes and Atypical Nevus Cells

(2008) Nico P. M. Smit et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling

(2008) J. C. Juarez et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reactive Oxygen Species May Have Antitumor Activity in Metastatic Melanoma

(2007) Rabiya S. Tuma   JNCI-Journal of the National Cancer Institute